Global Premenstrual Dysphoric Disorder (PMDD) Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: GFAB473B17DAEN
QYResearch

Abstracts

This report focuses on the global Premenstrual Dysphoric Disorder (PMDD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Premenstrual Dysphoric Disorder (PMDD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Teva
• Eli Liliy
• Pfizer
• Bayer
• GSK
• Apotex
• Bristol Laboratories
• Mylan
• Allergan

Market segment by Type, the product can be split into

• Table Product
• Inject Product
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Premenstrual Dysphoric Disorder (PMDD) status, future forecast, growth opportunity, key market and key players.
• To present the Premenstrual Dysphoric Disorder (PMDD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Premenstrual Dysphoric Disorder (PMDD) are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Premenstrual Dysphoric Disorder (PMDD) Revenue
1.4 Market Analysis by Type
  1.4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Table Product
  1.4.3 Inject Product
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Premenstrual Dysphoric Disorder (PMDD) Industry Impact
  1.6.1 How the Covid-19 is Affecting the Premenstrual Dysphoric Disorder (PMDD) Industry
    1.6.1.1 Premenstrual Dysphoric Disorder (PMDD) Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Premenstrual Dysphoric Disorder (PMDD) Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Premenstrual Dysphoric Disorder (PMDD) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Premenstrual Dysphoric Disorder (PMDD) Market Perspective (2015-2026)
2.2 Premenstrual Dysphoric Disorder (PMDD) Growth Trends by Regions
  2.2.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Premenstrual Dysphoric Disorder (PMDD) Historic Market Share by Regions (2015-2020)
  2.2.3 Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Premenstrual Dysphoric Disorder (PMDD) Market Growth Strategy
  2.3.6 Primary Interviews with Key Premenstrual Dysphoric Disorder (PMDD) Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Market Size
  3.1.1 Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Revenue (2015-2020)
  3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Players (2015-2020)
  3.1.3 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio
  3.2.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2019
3.3 Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Area Served
3.4 Key Players Premenstrual Dysphoric Disorder (PMDD) Product Solution and Service
3.5 Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Type (2015-2020)
4.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Type (2021-2026)

5 PREMENSTRUAL DYSPHORIC DISORDER (PMDD) BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020)
5.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size (2015-2020)
6.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in North America (2019-2020)
6.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020)
6.4 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size (2015-2020)
7.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Europe (2019-2020)
7.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020)
7.4 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020)

8 CHINA

8.1 China Premenstrual Dysphoric Disorder (PMDD) Market Size (2015-2020)
8.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in China (2019-2020)
8.3 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020)
8.4 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Premenstrual Dysphoric Disorder (PMDD) Market Size (2015-2020)
9.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Japan (2019-2020)
9.3 Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020)
9.4 Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size (2015-2020)
10.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020)
10.4 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020)

11 INDIA

11.1 India Premenstrual Dysphoric Disorder (PMDD) Market Size (2015-2020)
11.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in India (2019-2020)
11.3 India Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020)
11.4 India Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size (2015-2020)
12.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020)
12.4 Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Teva
  13.1.1 Teva Company Details
  13.1.2 Teva Business Overview and Its Total Revenue
  13.1.3 Teva Premenstrual Dysphoric Disorder (PMDD) Introduction
  13.1.4 Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020))
  13.1.5 Teva Recent Development
13.2 Eli Liliy
  13.2.1 Eli Liliy Company Details
  13.2.2 Eli Liliy Business Overview and Its Total Revenue
  13.2.3 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Introduction
  13.2.4 Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
  13.2.5 Eli Liliy Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview and Its Total Revenue
  13.3.3 Pfizer Premenstrual Dysphoric Disorder (PMDD) Introduction
  13.3.4 Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Bayer
  13.4.1 Bayer Company Details
  13.4.2 Bayer Business Overview and Its Total Revenue
  13.4.3 Bayer Premenstrual Dysphoric Disorder (PMDD) Introduction
  13.4.4 Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
  13.4.5 Bayer Recent Development
13.5 GSK
  13.5.1 GSK Company Details
  13.5.2 GSK Business Overview and Its Total Revenue
  13.5.3 GSK Premenstrual Dysphoric Disorder (PMDD) Introduction
  13.5.4 GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
  13.5.5 GSK Recent Development
13.6 Apotex
  13.6.1 Apotex Company Details
  13.6.2 Apotex Business Overview and Its Total Revenue
  13.6.3 Apotex Premenstrual Dysphoric Disorder (PMDD) Introduction
  13.6.4 Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
  13.6.5 Apotex Recent Development
13.7 Bristol Laboratories
  13.7.1 Bristol Laboratories Company Details
  13.7.2 Bristol Laboratories Business Overview and Its Total Revenue
  13.7.3 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Introduction
  13.7.4 Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
  13.7.5 Bristol Laboratories Recent Development
13.8 Mylan
  13.8.1 Mylan Company Details
  13.8.2 Mylan Business Overview and Its Total Revenue
  13.8.3 Mylan Premenstrual Dysphoric Disorder (PMDD) Introduction
  13.8.4 Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
  13.8.5 Mylan Recent Development
13.9 Allergan
  13.9.1 Allergan Company Details
  13.9.2 Allergan Business Overview and Its Total Revenue
  13.9.3 Allergan Premenstrual Dysphoric Disorder (PMDD) Introduction
  13.9.4 Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
  13.9.5 Allergan Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Premenstrual Dysphoric Disorder (PMDD) Key Market Segments
Table 2. Key Players Covered: Ranking by Premenstrual Dysphoric Disorder (PMDD) Revenue
Table 3. Ranking of Global Top Premenstrual Dysphoric Disorder (PMDD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Table Product
Table 6. Key Players of Inject Product
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Premenstrual Dysphoric Disorder (PMDD) Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Premenstrual Dysphoric Disorder (PMDD) Players to Combat Covid-19 Impact
Table 13. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2015-2020)
Table 17. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Premenstrual Dysphoric Disorder (PMDD) Market Growth Strategy
Table 23. Main Points Interviewed from Key Premenstrual Dysphoric Disorder (PMDD) Players
Table 24. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Players (2015-2020) (Million US$)
Table 25. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Players (2015-2020)
Table 26. Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2019)
Table 27. Global Premenstrual Dysphoric Disorder (PMDD) by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Premenstrual Dysphoric Disorder (PMDD) Product Solution and Service
Table 30. Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020) (Million US$)
Table 33. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Type (2015-2020)
Table 34. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2021-2026)
Table 35. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Application (2015-2020)
Table 36. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020) (Million US$)
Table 37. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Application (2021-2026)
Table 38. North America Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2019-2020)
Table 40. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020) (Million US$)
Table 41. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2015-2020)
Table 42. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020) (Million US$)
Table 43. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2015-2020)
Table 44. Europe Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2019-2020)
Table 46. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2015-2020)
Table 48. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2015-2020)
Table 50. China Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2019-2020) (Million US$)
Table 51. China Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2019-2020)
Table 52. China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020) (Million US$)
Table 53. China Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2015-2020)
Table 54. China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020) (Million US$)
Table 55. China Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2015-2020)
Table 56. Japan Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2019-2020)
Table 58. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2015-2020)
Table 60. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2019-2020)
Table 64. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2015-2020)
Table 66. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2015-2020)
Table 68. India Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2019-2020) (Million US$)
Table 69. India Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2019-2020)
Table 70. India Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020) (Million US$)
Table 71. India Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2015-2020)
Table 72. India Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020) (Million US$)
Table 73. India Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2019-2020)
Table 76. Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2015-2020)
Table 78. Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2015-2020)
Table 80. Teva Company Details
Table 81. Teva Business Overview
Table 82. Teva Product
Table 83. Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020) (Million US$)
Table 84. Teva Recent Development
Table 85. Eli Liliy Company Details
Table 86. Eli Liliy Business Overview
Table 87. Eli Liliy Product
Table 88. Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020) (Million US$)
Table 89. Eli Liliy Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. Bayer Company Details
Table 96. Bayer Business Overview
Table 97. Bayer Product
Table 98. Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020) (Million US$)
Table 99. Bayer Recent Development
Table 100. GSK Company Details
Table 101. GSK Business Overview
Table 102. GSK Product
Table 103. GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020) (Million US$)
Table 104. GSK Recent Development
Table 105. Apotex Company Details
Table 106. Apotex Business Overview
Table 107. Apotex Product
Table 108. Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020) (Million US$)
Table 109. Apotex Recent Development
Table 110. Bristol Laboratories Company Details
Table 111. Bristol Laboratories Business Overview
Table 112. Bristol Laboratories Product
Table 113. Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020) (Million US$)
Table 114. Bristol Laboratories Recent Development
Table 115. Mylan Business Overview
Table 116. Mylan Product
Table 117. Mylan Company Details
Table 118. Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020) (Million US$)
Table 119. Mylan Recent Development
Table 120. Allergan Company Details
Table 121. Allergan Business Overview
Table 122. Allergan Product
Table 123. Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020) (Million US$)
Table 124. Allergan Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Type: 2020 VS 2026
Figure 2. Table Product Features
Figure 3. Inject Product Features
Figure 4. Others Features
Figure 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Premenstrual Dysphoric Disorder (PMDD) Report Years Considered
Figure 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions: 2020 VS 2026
Figure 12. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Players in 2019
Figure 15. Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2019
Figure 17. North America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Teva Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
Figure 26. Eli Liliy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Eli Liliy Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
Figure 28. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Pfizer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
Figure 30. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bayer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
Figure 32. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GSK Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
Figure 34. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Apotex Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
Figure 36. Bristol Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol Laboratories Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
Figure 38. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Mylan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
Figure 40. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Allergan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed